Healthcare Nanotechnology (Nanomedicine) Market Size [2031]

Report Description

Healthcare Nanotechnology (Nanomedicine) Market Outlook 2031

The global healthcare nanotechnology (nanomedicine) market size was valued at USD 211.73 billion in 2023 and is likely to reach USD 562.1 billion by 2031, expanding at a CAGR of 13.14% during 2023 – 2031. The growth of the market is attributed to the rising advancement in nanomedicine technology.

Increasing occurrence of cancer is resulting in the growing utilization of advanced technologies, including nanomedicine, for effective and precise treatments, which further boosts the market. Nanomedicine is used to deliver chromatography drugs directly to cancer cells, minimizing harm to healthy tissues and reducing side effects. Additionally, nanoparticles improve the sensitivity of cancer diagnostics by improving antigen presentation and T-cell activation, thereby, propelling the demand for effective nanomedicine technologies.

• According to the report published by the World Cancer Research Fund International, in 2020, approximately 18.1 million cancer cases were registered worldwide, of which, 9.3 million cases were in men, while 8.8 million cases were in women.

Get Free Sample Report

Healthcare nanotechnology is known as nanomedicine. It refers to the field of science and technology that deals with the application of incredibly tiny materials at the nanoscale. These nanoscale materials are used in the medical field for various purposes, including diagnosis, treatment, and prevention of diseases. Moreover, these tiny materials are designed to interact with the human body at the cellular or even molecular level, allowing for highly targeted treatment delivery.

The COVID-19 pandemic moderately impacted the market. The pandemic highlighted the need for innovative and precise medical solutions. This, in turn, increased the utilization of nanotechnology in drug delivery, diagnostics, and treatments. On the other hand, the pandemic disrupted the global supply chain and resources, which affected the production and distribution of nanomedicine products.

Impact of Artificial Intelligence (AI) on Healthcare Nanotechnology (Nanomedicine) Market

Emergence of artificial intelligence is expected to propel the market. AI is helping in data processing and analysis of vast amounts of data and identifying potential solutions for precise drug delivery, disease detection, and treatment. AI-driven algorithms are aiding in the design of efficient and effective nanoscale materials. Furthermore, AI helps in accurate diagnosis and early disease detection, which improves diagnostic procedures.

Healthcare Nanotechnology (Nanomedicine) Market Dynamics

Get Free Sample Report

Major Drivers

Growing incidence of cardiovascular diseases is expected to drive the market. Cardiovascular diseases often involve intricate issues within blood vessels and the heart.

Nanomedicine allows for the design of nanoparticles that carry medications directly to affected areas and improves overall patient outcomes. Moreover, the rising number of deaths from heart diseases is further boosting the demand for nanomedicine technology.

• As per the report published by the World Health Organization (WHO) on June 11, 2021, in 2019, about 17.9 million individuals died due to cardiovascular diseases (CVDs), accounting for 32% of the total global deaths.

Existing Restraints

High development and production cost of nanomedicine devices and therapeutics is expected to hinder the market. Research and development activities often involve a substantial financial investment. High production costs limit their accessibility to a broad patient population. Moreover, stringent regulations for the commercial launch of nanomedicine products are likely to hamper the market.

Emerging Opportunities

Advancements in scientific research and innovation are expected to create immense opportunities for the key players competing in the market. Researchers are focusing on gaining a deep understanding of the genetic and molecular underpinnings of diseases, which enables them to design nanoscale interventions at the molecular level. Furthermore, the development of minimally invasive procedures through nanotechnology reduces patient trauma, thus boosting the market.

Scope of the Healthcare Nanotechnology (Nanomedicine) Market Report

The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Healthcare Nanotechnology (Nanomedicine) Market Segment Insights

Modality Segment Analysis

Based on modality, the healthcare nanotechnology (nanomedicine) market is bifurcated into diagnostics and treatment. The treatment segment is anticipated to register a robust growth rate during the forecast period, as nanotechnology provides effective tools and methods for delivering treatments.

Nanoparticles are designed to carry therapeutic agents directly to the site of action to maximize the impact of treatment. This targeted drug delivery enhances the effectiveness of treatment and reduces the side effects. These all factors are contributing to market growth.

Application Segment Analysis

On the basis of application, the market is classified as tissue regeneration, regenerative medicine, vaccines, drug delivery, diagnostics imaging, biomaterials, active implants, and others. The drug delivery segment is expected to expand at a considerable CAGR in the coming years, owing to the increasing utilization of nanomedicines for controlled drug release to cater to chronic diseases. Nanoparticles enable sustained drug delivery while reducing dosing frequency and maintaining consistent therapy. Moreover, the growing prevalence of chronic disease further boosts the segment.

Get Free Sample Report

Disease Segment Analysis

In terms of disease, the healthcare nanotechnology (nanomedicine) market is fragmented into infectious diseases, cardiovascular diseases, orthopedic diseases, oncological diseases, neurological diseases, and others. The oncological diseases segment is expected to hold a key market share during the projected period, due to the surge in oncology disorders and the growing disposable income among individuals.

Nanomedicine offers compelling alternatives to existing oncology treatment and diagnostic methods. Moreover, increasing utilization of nanotechnology in minimally invasive procedures in oncology procedures fuels the market.

The neurological diseases segment is projected to register a considerable CAGR during the forecast period, as nanotechnology in neurology minimizes damage to healthy brain tissue. Traditional treatments often affect both diseased and healthy brain cells, which leads to side effects and complications. However, the targeted approach of nanomedicine ensures that only the affected cells are treated, which further reduces side effects.

• As per the report published by the National Institute of Environmental Health Sciences, neurodegenerative conditions impact a large number of individuals globally. In 2022, around 6.2 million people in the US were affected by Alzheimer's disease. Furthermore, approximately one million people in America suffer from Parkinson's disease.

Regional Outlook

In terms of region, the global healthcare nanotechnology (nanomedicine) market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market in the coming years, due to the robust presence of nanotechnology-focused companies and startups. These companies often collaborate with research institutions and healthcare providers to develop and commercialize nanomedicine applications. Additionally, the presence of well-established and advanced healthcare infrastructure facilitates the adoption and integration of nanotechnology in healthcare and contributes to propelling the market.

The market in Asia Pacific is anticipated to expand at a rapid pace during the projection period, due to the rapidly growing population in the region. This demographic factor creates a substantial demand for advanced healthcare solutions, including nanomedicine. Furthermore, the rising prevalence of chronic diseases and infectious diseases in the region is projected to contribute to the growth of the market.

Get Free Sample Report